Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cyclic and bicyclic diamino histamine-3 receptor antagonists

Cyclic and bicyclic diamino histamine-3 receptor antagonists

US Patent 6559140 · Granted May 6, 2003

Estimated economic value: $101,709,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted bicyclic compounds useful as T cell activators2024
Naphthyridinone compounds useful as T cell activators2024
Substituted naphthyridinone compounds useful as T cell activators2023
Substituted naphthyridinone compounds useful as T cell activators2021
Modulators of the integrated stress pathway2021
Modulators of the integrated stress pathway2020
Modulators of the integrated stress pathway2020
Substituted naphthyridinone compounds useful as T cell activators2020
Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of u2020
Inhibitors of tyrosine kinase 2 mediated signaling2019
Indazolones as modulators of TNF signaling2019
Tricyclic modulators of TNF signaling2019